InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. It manages its business as one reportable segment, PACE.
Last trade$9.52
Day change-$0.065 (-0.68%)
Day range$9.38 – $10.21
Volume120,739
Market cap$1.31B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.31B
Price / earnings
145.3×
Price / book
5.12×
Price / sales
1.28×
EV / sales
1.23×
EV / EBITDA
31.82×
Profitability
Earnings per share
$0.07
Return on assets
1.6%
Return on equity
3.52%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.24×
Current ratio
1.16×
Quick ratio
1.16×
Cash ratio
0.62×
Cash flow
Price / cash flow
14.6×
Price / free cash flow
17.13×
Free cash flow
$76.31M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for INNV, quarterly periods
Line item
Q1 FY2027 Sep 30, 2026
Q4 FY2026 Jun 30, 2026
Q3 FY2026 Mar 31, 2026
Q2 FY2026 Dec 31, 2025
Q1 FY2026 Sep 30, 2025
Q4 FY2025 Jun 30, 2025
Q3 FY2025 Mar 31, 2025
Q2 FY2025 Dec 31, 2024
Revenue
$264.76M
$261.95M
$251.94M
$239.71M
$236.11M
$221.42M
$218.14M
$209M
Cost of revenue
$201.17M
$199.39M
$190.92M
$186.88M
$184.75M
$180.13M
$177.4M
$171.93M
Gross profit
$63.59M
$62.56M
$61.02M
$52.83M
$51.36M
$41.29M
$40.75M
$37.07M
Selling, general and administrative
$37.78M
$43.01M
$85.28M
$34.69M
$37.88M
$34.92M
$45.52M
$35.81M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$43.44M
$52.42M
$90.1M
$39.56M
$42.96M
$43.44M
$50.91M
$49.62M
Operating income
$20.15M
$10.15M
-$29.08M
$13.26M
$8.39M
-$2.15M
-$10.16M
-$12.56M
Interest expense
-$123K
-$772K
-$988K
$0
-$1.25M
-$893K
-$1.16M
$0
Income before taxes
$20.04M
$9.67M
-$29.77M
$12.46M
$7.92M
-$4.2M
-$11.06M
-$13.46M
Income taxes
-$841K
-$116K
$167K
$651K
$247K
$807K
$72K
$34K
Net income
$20.88M
$9.78M
-$29.94M
$11.81M
$7.67M
-$5.01M
-$11.13M
-$13.49M
Net income attributable to common shareholders
$19.55M
$8.29M
-$29.46M
$10.62M
$8.02M
-$785K
-$11.38M
-$13.22M
EBITDA
$25.81M
$19.55M
-$24.26M
$18.14M
$13.48M
$6.36M
-$4.77M
$1.26M
Basic earnings per share
$0.14
$0.06
-$0.22
$0.08
$0.06
-$0.01
-$0.08
-$0.10
Diluted earnings per share
$0.14
$0.06
-$0.22
$0.08
$0.06
-$0.01
-$0.08
-$0.10
Recent news
Company coverage with links to the original publishers.
InnovAge Holding Corp. reported Q3 2026 earnings of $0.14 per share, beating consensus estimates of $0.11, with a 27.27% earnings surprise. The company also exceeded revenue expectations at $264.76 million versus estimates of $255.2 million. However, the stock received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, suggesting near-term performance in line with the market. The Medical Services industry ranks in the top 40% of Zacks industries.
Pediatrix Medical Group reported Q3 2026 earnings of $0.72 per share, beating consensus estimates of $0.63 and surpassing revenue expectations. The company has outperformed the S&P 500 by 35.2% year-to-date. However, it received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, with the Medical Services industry ranking in the bottom 40% of sectors.
InnovAge Holding Corp. announced the pricing of a secondary offering of 10 million shares at $9.25 per share by investment funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe. The company will not receive proceeds from the sale but will bear associated costs. The offering is expected to close on September 24, 2026.
HealthEquity reported Q3 2026 earnings of $1.24 per share, beating consensus estimates of $1.19, with revenues of $350.73 million slightly exceeding expectations. The company has outperformed the S&P 500 by 2% year-to-date. However, the stock received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, suggesting near-term performance in line with the market.
InnovAge Holding Corp. (Nasdaq: INNV) announced it will release its fiscal third quarter 2026 financial results on May 5, 2026, after market close, followed by a conference call at 5 p.m. E.T. The company is a market leader in PACE (Program of All-inclusive Care for the Elderly) services, serving approximately 8,010 participants across 20 centers in six states as of December 31, 2025.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.